-Search query
-Search result
Showing 1 - 50 of 1,916 items for (author: lie & f)
EMDB-19986:
Structure of recombinant alpha-synuclein fibrils 1B capable of seeding GCIs in vivo
Method: helical / : Burger D, Kashyrina M, Lewis A, De Nuccio F, Mohammed I, de La Seigliere H, van den Heuvel L, Feuillie C, Verchere J, Berbon M, Arotcarena M, Retailleau A, Bezard E, Laferriere F, Loquet A, Bousset L, Baron T, Lofrumento DD, De Giorgi F, Stahlberg H, Ichas F
PDB-9euu:
Structure of recombinant alpha-synuclein fibrils 1B capable of seeding GCIs in vivo
Method: helical / : Burger D, Kashyrina M, Lewis A, De Nuccio F, Mohammed I, de La Seigliere H, van den Heuvel L, Feuillie C, Verchere J, Berbon M, Arotcarena M, Retailleau A, Bezard E, Laferriere F, Loquet A, Bousset L, Baron T, Lofrumento DD, De Giorgi F, Stahlberg H, Ichas F
EMDB-40815:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies C3V5, V1V3, N611 and base from participant 017
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-40816:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies gp41-N611/FP and base from participant 03
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-40817:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies gp41-N611/FP and base from participant 07
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-40818:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies gp120-GH and base from participant 09
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-40819:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies C3V5, V1V3, gp41-GH/FP and base from participant 11
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-42974:
Myxococcus xanthus EncA 3xHis pore mutant with T=1 icosahedral symmetry
Method: single particle / : Szyszka TN, Andreas MP, Lie F, Miller LM, Adamson LSR, Fatehi F, Twarock R, Draper BE, Jarrold MF, Giessen TW, Lau YH
EMDB-42975:
Myxococcus xanthus EncA 3xHis pore mutant with tetrahedral symmetry
Method: single particle / : Szyszka TN, Andreas MP, Lie F, Miller LM, Adamson LSR, Fatehi F, Twarock R, Draper BE, Jarrold MF, Giessen TW, Lau YH
PDB-8v4n:
Myxococcus xanthus EncA 3xHis pore mutant with T=1 icosahedral symmetry
Method: single particle / : Szyszka TN, Andreas MP, Lie F, Miller LM, Adamson LSR, Fatehi F, Twarock R, Draper BE, Jarrold MF, Giessen TW, Lau YH
PDB-8v4q:
Myxococcus xanthus EncA 3xHis pore mutant with tetrahedral symmetry
Method: single particle / : Szyszka TN, Andreas MP, Lie F, Miller LM, Adamson LSR, Fatehi F, Twarock R, Draper BE, Jarrold MF, Giessen TW, Lau YH
EMDB-41514:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-1 week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41515:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-1 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41516:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-1 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41517:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-1 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41518:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-2 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41519:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 2-1 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41520:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-2 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41521:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-2 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41522:
Polyclonal immune complex of fab binding the H2 HA from serum of subject 1-3 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41541:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-3 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41543:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-3 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41544:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-3 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41545:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-1 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41546:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-1 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41547:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-1 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41548:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-1 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41549:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-2 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41550:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-2 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41551:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-2 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41552:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-2 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41553:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-3 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41554:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-3 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41555:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-3 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41556:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-3 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41557:
Polyclonal immune complex of Fab binding the H1 HA from serum of subject 1-1 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41558:
Polyclonal immune complex of Fab binding the H1 HA from serum of subject 1-1 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41559:
Polyclonal immune complex of Fab binding the H1 HA from serum of subject 1-1 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-39126:
Structure of the FADD/Caspase-8/cFLIP death effector domain assembly
Method: single particle / : Lin SC, Yang CY
EMDB-39127:
Structure of the FADD/Caspase-8/cFLIP death effector domain assembly
Method: single particle / : Lin SC, Yang CY
PDB-8ybx:
Structure of the FADD/Caspase-8/cFLIP death effector domain assembly
Method: single particle / : Lin SC, Yang CY
EMDB-42464:
chEnv TTT protein in complex with 43A2 Fab
Method: single particle / : Ozorowski G, Lee WH, Ward AB
EMDB-42468:
chEnv TTT protein in complex with CM01A Fab
Method: single particle / : Ozorowski G, Lee WH, Ward AB
EMDB-43664:
Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines
Method: single particle / : Ferguson JA, Leon AN, Ward AB
EMDB-43665:
Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines (cH125 TTT)
Method: single particle / : Ferguson JA, Leon AN, Ward AB
EMDB-43666:
Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines (H2/1 GCN4)
Method: single particle / : Ferguson JA, Leon AN, Ward AB
EMDB-43668:
Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines (H5/1 GCN4)
Method: single particle / : Ferguson JA, Leon AN, Ward AB
EMDB-43669:
Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines. H5 GCN4
Method: single particle / : Ferguson JA, Leon AN, Ward AB
EMDB-19562:
Vimentin intermediate filament protofibril stoichiometry
Method: subtomogram averaging / : Eibauer M, Medalia O
EMDB-19563:
Vimentin intermediate filament structure (delta tail)
Method: helical / : Eibauer M, Medalia O
Pages: